Pmv Pharmaceuticals Valuation
| PMVP Stock | USD 1.67 0.08 4.57% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Pmv Pharmaceuticals holds a recent Real Value of $4.55 per share. The prevailing price of the company is $1.67. Our model determines the value of Pmv Pharmaceuticals from analyzing the company fundamentals such as Shares Owned By Institutions of 84.42 %, return on equity of -0.24, and Shares Outstanding of 51.52 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Pmv Pharmaceuticals' valuation include:
Price Book 0.4015 | Enterprise Value -113.9 M | Enterprise Value Ebitda 1.2385 |
Undervalued
Today
Please note that Pmv Pharmaceuticals' price fluctuation is slightly risky at this time. Calculation of the real value of Pmv Pharmaceuticals is based on 3 months time horizon. Increasing Pmv Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Pmv Pharmaceuticals' intrinsic value may or may not be the same as its current market price of 1.67, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.67 | Real 4.55 | Target 13.2 | Hype 1.69 | Naive 1.7 |
The intrinsic value of Pmv Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pmv Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pmv Pharmaceuticals helps investors to forecast how Pmv stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pmv Pharmaceuticals more accurately as focusing exclusively on Pmv Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Pmv Pharmaceuticals' intrinsic value based on its ongoing forecasts of Pmv Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Pmv Pharmaceuticals' closest peers.
Pmv Pharmaceuticals Cash |
|
Pmv Valuation Trend
Pmv Pharmaceuticals' real value is important for investors to make better decisions and a more accurate overall view of Pmv Pharmaceuticals' financial worth over time. Using both Pmv Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Pmv Pharmaceuticals Total Value Analysis
Pmv Pharmaceuticals is at this time anticipated to have valuation of (113.89 M) with market capitalization of 86.42 M, debt of 13.29 M, and cash on hands of 277.43 M. The negative valuation of Pmv Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Pmv Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(113.89 M) | 86.42 M | 13.29 M | 277.43 M |
Pmv Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Pmv is to check how much profit was generated for every dollar of assets it reports. Pmv Pharmaceuticals holds a negative application of assets of -0.2 pct., losing $0.002027 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Pmv Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Pmv Pharmaceuticals Ownership Allocation
Pmv Pharmaceuticals owns a total of 51.52 Million outstanding shares. The majority of Pmv Pharmaceuticals outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Pmv Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Pmv Pharmaceuticals. Please pay attention to any change in the institutional holdings of Pmv Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Pmv Pharmaceuticals Profitability Analysis
Net Loss for the year was (68.96 M) with profit before overhead, payroll, taxes, and interest of 0.About Pmv Pharmaceuticals Valuation
The stock valuation mechanism determines Pmv Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Pmv Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pmv Pharmaceuticals. We calculate exposure to Pmv Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pmv Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -1.3 M | -1.2 M |
Pmv Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Pmv Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 48 M |
Pmv Pharmaceuticals Current Valuation Indicators
Pmv Pharmaceuticals' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Pmv Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Pmv Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Pmv Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Pmv Pharmaceuticals' worth.Additional Tools for Pmv Stock Analysis
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.